| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 49.4% | -144.7% |
| ROCE | 51.5% |
| Latest | F'cast | |
|---|---|---|
| P/E | 9.8 | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 5.3 | 22.4 |
| Pr/Book | 7.3 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 655.7% | -76.2% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-06 | 0.07 | (6.01) | (3.51)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-07 | 0.27 | (5.46) | (3.96)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-08 | 0.85 | (4.79) | (3.46)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-09 | 1.31 | (4.20) | (3.02)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-10 | 9.87 | 4.59 | 2.79p | 12.5 | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-11 | 2.35 | (3.40) | (1.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-12 | 2.90 | (3.20) | (1.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 12.25 | 5.70 | 1.60p | 17.1 | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Total Voting Rights | 30-Apr-2012 | 07:00 | RNS |
| Stroke biomarker license to Randox | 05-Apr-2012 | 07:00 | RNS |
| Block Admission Return | 29-Mar-2012 | 17:11 | RNS |
| Proteome issues new licence for stroke product | 05-Apr-2012 | ShareCast |
| Proteome rockets on Alzheimer's blood test | 28-Mar-2012 | ShareCast |
| Stroke consortium to get €11m grant | 19-Mar-2012 | ShareCast |
| Mad cow deal beefs up Proteome | 02-Apr-2003 | Daily Mail |
| Master stroke by dad whose daughter died | 03-May-2002 | Sun |
| Tests boost for Proteome | 03-May-2002 | The Scotsman |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 27.38p |
| Change Today | 0.25p |
| % Change | 0.92 % |
| 52 Week High | 41.00p |
| 52 Week Low | 17.25p |
| Volume | 19,836 |
| Shares Issued | 192.50m |
| Market Cap | £52.70m |
| Beta | 0.31 |
| RiskGrade | 292 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 0 |
| Buy | 0 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 10:42 | 3,724 @ 27.06p |
| 09:36 | 11,112 @ 27.00p |
| 09:15 | 5,000 @ 27.93p |
| CEO | Christopher Pearce |
| Finance Director | James L Malthouse |
| COO | Ian Pike |
You are here: research